However, when ectopically expressed in IBC cells, DCN overexpression or DCN protein treatment significantly affects the expression of E-cadherin and EGFR–ERK activity as well as the invasion and development of IBC tumors. This evidence concerns the gene CDH1 and inflammatory breast carcinoma.